Nicotine therapeutic benefits: Difference between revisions

Line 917: Line 917:
*Citation: Berry KM, Reynolds LM, Collins JM, et alE-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013–2015Tobacco Control 2019;28:42-49.
*Citation: Berry KM, Reynolds LM, Collins JM, et alE-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013–2015Tobacco Control 2019;28:42-49.
*Acknowledgement: Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the Center for Tobacco Products under Award Number P50HL120163.
*Acknowledgement: Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the Center for Tobacco Products under Award Number P50HL120163.
===2018: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751520/ E-cigarette Usage Is Associated With Increased Past-12-Month Quit Attempts and Successful Smoking Cessation in Two US Population–Based Surveys]===
*Compared with 2006, past-12-month quit attempts and smoking cessation increased among adults aged 25–44 in recent years. Current e-cigarette use was associated with increased past-12-month quit attempts and successful smoking cessation among established smokers. These findings are relevant to future tobacco policy decisions.
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751520/pdf/nty211.pdf PDF Version]
*Citation: Johnson L, Ma Y, Fisher SL, et al. E-cigarette Usage Is Associated With Increased Past-12-Month Quit Attempts and Successful Smoking Cessation in Two US Population-Based Surveys. Nicotine Tob Res. 2019;21(10):1331-1338. doi:10.1093/ntr/nty211
*Acknowledgement: Research reported in this paper was supported by National Institute on Drug Abuse (NIDA) grants R01DA036583 (LJB), R01DA042195 (RAG), R01DA038076 (LSC), R21DA033827 (RCC), and K12DA041449 (ATR); National Cancer Institute (NCI) grants U19CA203654 (LJB), P30CA091842 (LJB), and P30CA091842-16S2 (LSC); National Heart, Lung, and Blood Institute (NHLBI) grant R01HL109031 (TBB), National Institute on Alcohol Abuse and Alcoholism grant R21AA024888 (SMH), National Center For Advancing Translational Sciences grant TL1TR002344 (LJ), a grant from the Foundation for Barnes-Jewish Hospital (ATR), and by Grant 2015215 from the Doris Duke Charitable Foundation (SMH).